[Federal Register Volume 78, Number 249 (Friday, December 27, 2013)]
[Notices]
[Pages 79018-79019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-31026]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Request for a License To Export Deuterium
Pursuant to 10 CFR 110.70 (b) ``Public Notice of Receipt of an
Application,'' please take notice that the U.S. Nuclear Regulatory
Commission (NRC) has received the following request for an export
license. Copies of the request are available electronically through
ADAMS and can be accessed through the Public Electronic Reading Room
(PERR) link http://www.nrc.gov/reading-rm.html at the NRC Homepage.
A request for a hearing or petition for leave to intervene may be
filed within thirty days after publication of this notice in the
Federal Register. Any request for hearing or petition for leave to
intervene shall be served by the requestor or petitioner upon the
applicant, the Office of the General Counsel, U.S. Nuclear Regulatory
Commission, Washington, DC 20555; the Office of Secretary, U.S. Nuclear
Regulatory Commission, Washington, DC 20555; and the Executive
Secretary, U.S. Department of State, Washington, DC 20520.
A request for a hearing or petition for leave to intervene may be
filed with the NRC electronically in accordance with NRC's E-Filing
rule promulgated in August 2007, 72 FR 49139 (Aug. 28, 2007).
Information about filing electronically is available on the NRC's
public Web site at http://www.nrc.gov/site-help/e-submittals.html. To
ensure timely electronic filing, at least 5 (five) days prior to the
filing deadline, the petitioner/requestor should contact the Office of
the Secretary by email at [email protected], or by calling (301)
415-1677, to request a digital ID certificate and allow for the
creation of an electronic docket.
In addition to a request for hearing or petition for leave to
intervene, written comments, in accordance with 10 CFR 110.81, should
be submitted within thirty (30) days after publication of this notice
in the Federal Register to Office of the Secretary, U.S. Nuclear
Regulatory Commission, Washington, DC 20555, Attention: Rulemaking and
Adjudications.
The information concerning this export license application follows.
[[Page 79019]]
NRC Export License Application
[Description of material]
----------------------------------------------------------------------------------------------------------------
Name of applicant, date of
application, date received, Material type Total quantity End use Recipient country
application no., docket no.
----------------------------------------------------------------------------------------------------------------
Concert Pharmaceuticals, Inc.... Heavy water (D2O). ~20,000.0 kgs..... Non-nuclear end- Portugal, Austria
August 29, 2013................. use in active
December 5, 2013................ pharmaceutical
XMAT431......................... ingredient
11006131........................ manufacturing..
----------------------------------------------------------------------------------------------------------------
Dated this 20th day of December 2013 in Rockville, Maryland.
For the Nuclear Regulatory Commission.
Stephen Dembek,
Acting Deputy Director, Office of International Programs.
[FR Doc. 2013-31026 Filed 12-26-13; 8:45 am]
BILLING CODE 7590-01-P